A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
Study sponsor: Journey Medical Corporation
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-06-30Actual
Enrollment · participants323Actual
Source updated2024-12-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.